Paul Spence
Corporate Officer/Principal bei OPTINOSE, INC.
Vermögen: 272 889 $ am 31.05.2024
Ursprung des Netzwerks ersten Grades von Paul Spence
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 19 | |
| Subsidiary | Pharmaceuticals: Major | 16 | |
Nestle Health Science SA
 Nestle Health Science SA Pharmaceuticals: OtherHealth Technology Nestle Health Science SA develops nutritional therapies. Its health management services include aging, brain health, chronic medical conditions, critical care and surgery, food allergy, gastro intestinal, metabolic diseases, and obesity pediatrics. The company was founded in 2011 and is headquartered in Vevey, Switzerland.
3
| Subsidiary | Pharmaceuticals: Other | 3 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Paul Spence
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal General Counsel | |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Pharmaceuticals: Major | Director of Finance/CFO Chief Tech/Sci/R&D Officer | |
| SUMITOMO PHARMA CO., LTD. | Pharmaceuticals: Major | Chief Executive Officer | |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Biotechnology | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Chairman Chief Tech/Sci/R&D Officer General Counsel Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Sumitomo Pharma America, Inc.
 Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Pharmaceuticals: Major | Chief Executive Officer | |
| ARTHROCARE CORPORATION | Medical Specialties | Director/Board Member | |
| PHARMACYCLICS, INC. | Pharmaceuticals: Major | Director/Board Member Chief Tech/Sci/R&D Officer | |
| COVANCE INC. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| NESTLÉ S.A. | Food: Major Diversified | Corporate Officer/Principal Corporate Officer/Principal | |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Janssen Pharmaceuticals, Inc.
 Janssen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Janssen Pharmaceuticals, Inc. develops and markets prescription drugs in various therapeutic areas, including attention deficit hyperactivity disorder, pain management, acid reflux and infectious diseases, women’s health, and mental health (bipolar I disorder and schizophrenia); and neurologic, including Alzheimer’s disease, epilepsy, and migraine prevention and treatment. Its products include Axert, Darzalezx, Invokamet XR, Invokana, Remicade, Reopro, and Risperdal Consta. The company was founded by Paul Janssen in 1953 and is headquartered in Titusville, NJ. | Pharmaceuticals: Major | President Chief Tech/Sci/R&D Officer | |
Cerecin, Inc.
 Cerecin, Inc. Pharmaceuticals: MajorHealth Technology Cerecin, Inc. develops therapies to treat central nervous system disorders. It offers therapeutic treatments for Parkinson's disease, Alzheimer's disease, and other age-related memory loss disorders. The firm is also developing therapies that address metabolic deficiencies and provide an alternative energy source for brain cells. The company was founded in 2001 and is headquartered in Boulder, CO. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| CODEXIS, INC. | Chemicals: Specialty | Director/Board Member Chief Administrative Officer | |
Take Care Health Systems LLC
 Take Care Health Systems LLC Medical/Nursing ServicesHealth Services Take Care Health Systems, Inc. provides health care services. It offers minor injuries, physicals, vaccinations, skin conditions, ongoing health conditions, medications and treatments. The company was founded by Peter K. Miller and Hal F. Rosenbluth in October, 2004 and is headquartered in West Conshohocken, PA. | Medical/Nursing Services | Chief Executive Officer Corporate Officer/Principal | |
Mylan, Inc.
 Mylan, Inc. Pharmaceuticals: MajorHealth Technology Mylan, Inc. develops, manufactures, and licenses generic pharmaceuticals. The firm operates its business through two segments: Generics and Specialty. The Generics segment primarily develops, manufactures, sells and distributes generic or branded generic pharmaceutical products in tablet, capsule, injectable or transdermal patch form, as well as API. The Specialty segment engages mainly in the development, manufacture and sale of branded specialty nebulized and injectable products. The company was founded by Milan Puskar and Don Panoz in 1961 and is headquartered in Canonsburg, PA. | Pharmaceuticals: Major | General Counsel | |
| KALA BIO, INC. | Pharmaceuticals: Major | Chief Executive Officer | |
| Dartmouth College | College/University | Undergraduate Degree Undergraduate Degree | |
Novartis Pharmaceuticals UK Ltd.
 Novartis Pharmaceuticals UK Ltd. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals UK Ltd. manufactures medicines and drugs. The company is headquartered in Camberley, the United kingdom. | Pharmaceuticals: Major | Corporate Officer/Principal | |
Nestlé España SA
 Nestlé España SA Food: Major DiversifiedConsumer Non-Durables Part of Nestlé SA, Nestlé España SA is a food and beverage company based in Esplugues de Llobregat, Spain. Nestlé is the world's largest food and Spanish beverage company, unlocking the power of food to enhance the quality of life for everyone, today and for generations to come. | Food: Major Diversified | Corporate Officer/Principal | |
Astra Merck, Inc.
 Astra Merck, Inc. Pharmaceuticals: MajorHealth Technology Part of AstraZeneca PLC, Astra Merck, Inc. is a company that sells pharmaceutical products. The company is based in Orlando, FL. The company was founded by Myrtle S. Potter, Thomas A. McCourt. Astra Merck was acquired by Astra AB from Merck & Co., Inc. on July 12, 1998 for $4,400 million. | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of California, Los Angeles | College/University | Undergraduate Degree Graduate Degree Undergraduate Degree | |
| Ball State University (Indiana) | College/University | Undergraduate Degree | |
Prometheus Laboratories, Inc.
 Prometheus Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Prometheus Laboratories, Inc. develops and commercializes novel pharmaceutical and diagnostic products. Its enables physicians to provide individualized patient care. It applies the principles of personalized medicine to the diagnosis and treatment of gastrointestinal diseases and applies it to oncology. The firms markets and promotes pharmaceutical products and complementary proprietary diagnostic testing services. The company was founded by Jonathan Braun, Stephan R. Targan, Michael J. Walsh, and Scott L. Glenn in 1995 and is headquartered in San Diego, CA. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Novartis Pharmaceuticals Corp.
 Novartis Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Novartis Pharmaceuticals Corp. develops, manufactures, and markets prescription drugs. It manufactures and markets prescription drugs used to treat a number of diseases and conditions including cardiovascular, dermatological, central nervous system, bone disease, cancer, organ transplantation, psychiatry, infectious disease, and respiratory. The company was founded in 1996 and is headquartered in East Hanover, NJ. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Universidad de Buenos Aires | College/University | Doctorate Degree | |
Janssen Pharmaceutica NV
 Janssen Pharmaceutica NV Pharmaceuticals: MajorHealth Technology Janssen Pharmaceutica NV engages in the development of medical solutions. It offers research and development services in the field of mental illness, neurological disorders, anesthesia, analgesia, gastrointestinal disorders, fungal infection, allergies and cancer. The firms products include Zytiga, Caelyx, Dacogen, Edurant, Fentanyl-Janssen, Intelence, Leustatin, , Pariet, and Reminyl. The company was founded in 1953 by Paul Janssen and is headquartered in Beerse, Belgium. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
| American Red Cross Bay Area | Director/Board Member | ||
Optinose AS
 Optinose AS Medical SpecialtiesHealth Technology OptiNose AS develops, produces, administers, commercializes, and distributes exhalation drug delivery systems. It offers single and multi-use intranasal delivery devices for liquid and powder formulations. The company was founded on September 9, 2007 and is headquartered in Oslo, Norway. | Medical Specialties | Chief Executive Officer Director/Board Member | |
Nestlé Portugal, Unipessoal Lda.
 Nestlé Portugal, Unipessoal Lda. Food: Specialty/CandyConsumer Non-Durables Part of Nestlé SA, Nestlé Portugal, Unipessoal Lda. is a food and drink company founded in 1923 and based in Linda-a-Velha, Portugal. Nestlé is the largest food and drink Portuguese company worldwide, with over 2000 global and local brands, and a presence in 189 countries. The company provides a directory of office locations and contact details, as well as consumer services information. | Food: Specialty/Candy | President | |
Civitas Therapeutics, Inc.
 Civitas Therapeutics, Inc. BiotechnologyHealth Technology Civitas Therapeutics, Inc. develops transformative pulmonary delivery therapies. The company was founded by Glenn Batchelder, Richard P. Batycky, Martin I. Freed, Jennifer Fujii, Jeffrey Elton and James L. Wright on June 17, 2009 and is headquartered in Ardsley, NY. | Biotechnology | Chief Executive Officer | |
| JAZZ PHARMACEUTICALS PLC | Pharmaceuticals: Major | Director of Finance/CFO Director/Board Member | |
Nestle Health Science SA (Private Equity)
 Nestle Health Science SA (Private Equity) Investment ManagersFinance Nestle Health Science SA (Private Equity) is a private equity firm headquarter in Switzerland. It was founded in 2010 by Jason Brown and Persona. | Investment Managers | Chief Executive Officer Chief Executive Officer | |
| The Wharton School of the University of Pennsylvania | College/University | Masters Business Admin Masters Business Admin | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin Masters Business Admin Masters Business Admin | |
OptiNose US, Inc.
 OptiNose US, Inc. Pharmaceuticals: MajorHealth Technology OptiNose US, Inc. operates as a a specialty pharmaceutical company. it specializes on the development and commercialization of products for patients cared for by, or in consultation with, ear, nose, and throat (ENT) or allergy specialists. its products include XHANCE, ONZETRA, and Xsail. The company was founded by Per Gisle Djupesland and Helena Kytttari Djupesland in 2000 and is headquartered in Yardley, PA. | Pharmaceuticals: Major | Chairman Director/Board Member Chief Executive Officer President Director/Board Member | |
| SHIELD THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
| MVM Partners LLC | Investment Managers | Private Equity Investor Private Equity Investor | |
| AKERO THERAPEUTICS, INC. | Pharmaceuticals: Major | Chairman Director/Board Member | |
Nestlé Health Science (Deutschland) GmbH
 Nestlé Health Science (Deutschland) GmbH Pharmaceuticals: OtherHealth Technology Nestlé Health Science (Deutschland) GmbH is a company based in Frankfurt, Germany. Part of Nestlé SA, the German company develops nutritional therapies. The company was founded in 2011 and the CEO is Arne Ingo Jurk. | Pharmaceuticals: Other | Director/Board Member Director/Board Member | |
Aimmune Therapeutics UK Ltd.
 Aimmune Therapeutics UK Ltd. Pharmaceuticals: MajorHealth Technology Part of Stallergenes Greer Ltd., Aimmune Therapeutics UK Ltd. is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Cheltenham, UK. Aimmune Therapeutics was founded in 2015. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
Rivus Pharmaceuticals, Inc.
 Rivus Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rivus Pharmaceuticals, Inc. is a company dedicated to improving metabolic health by advancing a new class of medicines called controlled metabolic accelerators (CMAs). The company is based in Charlottesville, VA. Jayson Donald Alexander Dallas has been the CEO of the company since 2021. The company is a leader in mitochondrial biology and is developing a new class of medicines to address a primary driver of cardio-metabolic disease: obesity. Rivus' lead CMA is the investigational small molecule HU6 in development to treat obesity and associated metabolic diseases, including heart failure with preserved ejection fraction (HFpEF), metabolic dysfunction-associated steatotic liver disease (MASLD)/metabolic dysfunction-associated steatohepatitis (MASH), and type 2 diabetes. | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| VERA THERAPEUTICS, INC. | Biotechnology | Director/Board Member Corporate Officer/Principal | |
| JASPER THERAPEUTICS, INC. | Financial Conglomerates | Chief Tech/Sci/R&D Officer Corporate Officer/Principal |
Statistik
International
| Vereinigte Staaten | 37 |
| Vereinigtes Königreich | 4 |
| Irland | 3 |
| Schweiz | 3 |
| Japan | 2 |
Sektoral
| Health Technology | 36 |
| Consumer Services | 7 |
| Consumer Non-Durables | 4 |
| Finance | 4 |
| Process Industries | 2 |
Operativ
| Director/Board Member | 238 |
| Corporate Officer/Principal | 81 |
| Independent Dir/Board Member | 80 |
| Chairman | 39 |
| Undergraduate Degree | 31 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Patrick Enright | 41 |
| Mark McDade | 35 |
| Luis Cantarell Rocamora | 35 |
| Kathryn Falberg | 30 |
| R. Fletcher | 30 |
| Mark Iwicki | 26 |
| Joseph Scodari | 24 |
| Sandra Helton | 22 |
| Stacey Seltzer | 21 |
| Eric Bjerkholt | 21 |
| Grégory Behar | 20 |
| Tomas Jan Heyman | 18 |
| Eric Bednarski | 18 |
| Joao Siffert | 14 |
| Daniel Adelman | 13 |
- Börse
- Insiders
- Paul Spence
- Unternehmensverbindungen